Skip to main content
Clinical Trials/NCT06660706
NCT06660706
Recruiting
Not Applicable

The Effects of Exercise Intervention on Skeletal Muscle and Other Organs in Aged Population and the Discovery of Associated Circulating Biomarkers

National Yang Ming Chiao Tung University1 site in 1 country100 target enrollmentApril 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Age-related Functional Decline
Sponsor
National Yang Ming Chiao Tung University
Enrollment
100
Locations
1
Primary Endpoint
Change in Physical performance
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This project aims to investigate the intricate interplay between skeletal muscle and adipose tissue during the aging process by integrating human studies. Utilizing interventional research and randomized trials combined with examining blood samples from elderly individuals engaged in exercise, we aim to investigate the effects of exercise on muscle health and explore the underlying mechanisms of muscle aging and related biomarkers. Interdisciplinary research allowed us to investigate the systemic impact of exercise on muscles. This approach allowed us to gain a better understanding of the interconnectedness of skeletal muscle and adipose tissue in the aging process and devise efficient strategies to reverse age-related changes. These findings hold promise for promoting a future society where long and healthy life is achievable for all.

Detailed Description

This study is a randomized controlled trial of 6-month multidomain intervention program among community-living older adults with early physical impairments. Inclusion criteria are: (1) community-dwelling adults aged ≥ 65 years, (2) slow gait speed (\<1 m/s in 6-meter walk test) or weakness (dominant handgrip strength \<28 kg in men, \<18 kg in women); subjects with the following conditions will be excluded: (1) established diagnosis of dementia, Parkinsonism or other neurodegenerative disease (2) disable status: mobilitylimiting conditions, (3) active, acute diseases receiving treatment, such as cancer, heart failure, COPD and so on, (4) estimated life expectancy \<12 months, (5) current nursing home residents.

Registry
clinicaltrials.gov
Start Date
April 1, 2024
End Date
December 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Li-Ning Peng

Professor

National Yang Ming Chiao Tung University

Eligibility Criteria

Inclusion Criteria

  • aged ≥ 65 years
  • slow gait speed (\<1 m/s in 6-meter walk test) or weakness (dominant handgrip strength \<28 kg in men, \<18 kg in women)

Exclusion Criteria

  • established diagnosis of dementia, Parkinsonism or other mobility-limiting, disable conditions
  • active, acute diseases receiving treatment, such as cancer, heart failure, COPD and so on
  • estimated life expectancy \<12 months
  • current nursing home residents

Outcomes

Primary Outcomes

Change in Physical performance

Time Frame: baseline, 6 month

Change in hand-grip strength (kg), or six-meter walking speed (m/s), or 5 times sit to stand test from baseline to 6 months in all participants

Secondary Outcomes

  • Change in DHEA-S(baseline, 6 month)
  • Change in IGF-1(baseline, 6 month)
  • Change in hs-CRP(baseline, 6 month)
  • Change in Myostatin(baseline, 6 month)
  • Change in Activing A(baseline, 6 month)
  • Change in Follistatin(baseline, 6 month)
  • Change in Relative appendicular skeletal muscle index (RASM)(baseline, 6 month)
  • Change in body fat %(baseline, 6 month)
  • Change in Cognitive performance(baseline, 6 month)
  • Change from lipoproflie(baseline, 6 month)

Study Sites (1)

Loading locations...

Similar Trials